Kyle Munz

HeartSense’s Mission to Reveal, Combat Hidden CV Burdens in Underserved Communities

HeartSense is a Louisiana-based nonprofit community organization whose mission is to better understand the disparities, heart health needs, and prevalence of heart disease affecting underserved, rural populations. Antoine Keller, MD, FACC, FACS, cardiothoracic surgeon, Ochsner Lafayette General Hospital, and founder […]

HeartSense’s Mission to Reveal, Combat Hidden CV Burdens in Underserved Communities Read More »

Dr Dan Bloomfield Elaborates on Novel Findings From AZALEA-TIMI 71 Trial, Future of FXI Inhibitor Abelacimab

The AZALE-TIMI 71 study was designed to investigate the efficacy of abelacimab, an investigational, fully human monoclonal antibody that closely binds with factor XI (FXI), versus rivaroxaban to reduce bleeding risks in patients with atrial fibrillation. This investigation carries important

Dr Dan Bloomfield Elaborates on Novel Findings From AZALEA-TIMI 71 Trial, Future of FXI Inhibitor Abelacimab Read More »